Integruojančios medicinos ir sveikatingumo centras, VšĮ - financials and debts
Company age: 10 y. 0 mo.
Integruojančios medicinos ir sveikatingumo centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 24,342 | 17,660 | 19,582 | 22,033 | 29,763 | 34,442 | 26,827 |
| Profit before tax | - | - | - | - | -521 | 197 | 891 | -264 |
| Net profit | - | - | - | - | -521 | 197 | 891 | -264 |
| Equity | -9,693 | -8,557 | -5,785 | -5,775 | -6,297 | -6,100 | -5,209 | -5,217 |
| Liabilities | 11,386 | 8,686 | 7,143 | 6,547 | 7,877 | 6,829 | 6,541 | 7,629 |
| Non-current assets | 909 | 0 | 0 | 0 | 0 | 0 | 0 | 327 |
| Current assets | 784 | 129 | 1,358 | 772 | 1,580 | 729 | 1,332 | 2,085 |
| Total assets | 1,693 | 129 | 1,358 | 772 | 1,580 | 729 | 1,332 | 2,412 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,091 | 4,729 | 3,247 |
| Social insurance contributions | - | - | - | - | - | 4,906 | 5,604 | 4,043 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | -27.5% | +10.9% | +12.5% | +35.1% | +15.7% | -22.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | -33.0% | 27.0% | 66.9% | -10.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | -2.4% | 0.7% | 2.6% | -1.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | -2.4% | 0.7% | 2.6% | -1.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 3,108 | 2,523 | 2,797 | 2,618 | 3,307 | 4,217 | 3,743 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Integruojančios medicinos ir sveikatingumo centras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-03-18 | 2025-03-31 | 148.21 |
| 2024-09-17 | 2024-10-13 | 0.46 |
| 2024-08-19 | 2024-09-03 | 0.46 |
| 2024-07-24 | 2024-08-04 | 0.46 |
| 2024-05-16 | 2024-05-27 | 46.97 |
| 2024-04-16 | 2024-05-05 | 46.97 |
Integruojančios medicinos ir sveikatingumo centras - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Integruojančios medicinos ir sveikatingumo centras is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-06-30 | 2026-09-02 | 0.2 |
| 2026-05-14 | 2026-06-29 | 0.59 |
| 2026-05-13 | 2026-05-13 | 0.05 |
| 2025-04-10 | 2025-04-10 | 148.87 |
| 2025-03-15 | 2025-03-19 | 13.67 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Integruojancios medicinos ir sveikatingumo centras, VšI (code 304392427) is a Lithuanian Public Institution engaged in medical specialists activities. In 2025, revenue amounted to EUR 26.8K, down 22.1% year on year and 9.9% compared with 2023. The company moved from a small profit of EUR 197 in 2023 to EUR 891 in 2024, before reporting a net loss of EUR 264 in 2025, which pushed the profit margin to -1.0%. The three-year pattern shows a revenue peak in 2024 followed by a weaker 2025 result. On the balance sheet, total assets increased to EUR 2.4K in 2025 from EUR 1.3K in 2024, while equity stayed negative at EUR -5.2K and liabilities rose to EUR 7.6K. Long-term assets were EUR 327 and short-term assets EUR 2.1K. The latest figures indicate high asset turnover of 11.12x, but also a negative return on assets and continued negative equity. Revenue per employee was EUR 3.8K, with profit per employee at EUR -38.